Angioplasty Balloons Market By Type (Normal Balloons, Drug Eluting Balloons, Cutting Balloons, Scoring Balloons) , By Application (Peripheral, Coronary) By End User (ASCs, Hospitals, Cath Labs) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The angioplasty balloons market was valued at $2.6 billion in 2023, and is projected to reach $3.6 billion by 2033, growing at a CAGR of 3.4% from 2024 to 2033.
Angioplasty balloon is a minimally invasive endovascular device is used to open up blocked or narrowed blood vessels. This device enables to restore proper blood flow, alleviating the symptoms of coronary artery disease, heart attacks, and other cardiac diseases. The procedure is generally less expensive than open heart surgery, making it a cost-effective option for many patients.
The growth of the global angioplasty balloons market is driven by alarming increase in prevalence of cardiovascular diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases. As per the article published by the Revista Española de Cardiología—the official publication of the Spanish Society of Cardiology—coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers like angioplasty due to quicker recovery times and reduced hospital stays foster the growth of the market. However, high cost of angioplasty and complications associated with angioplasty, such as arterial dissection or restenosis hamper the market growth. On the contrary, continuous improvements in balloon design, materials, and imaging technologies will enhance the efficacy and safety of angioplasty procedures, which are expected to offer remunerative opportunities for the expansion of the market during the forecast period.
The global angioplasty balloons market is segmented into type, application, end user, and region. On the basis of type, the market is classified into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. By application, it is bifurcated into peripheral and coronary. Depending on end user, it is segregated into ASCs, hospitals, and Cath labs. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the normal balloon segment was the major revenue generator in 2023.
By application, the coronary segment accounted for the largest share in 2023 in angioplasty balloons market.
Depending on end user, the ASCs segment held the was the key shareholder in 2023.
Region wise, North America generated the highest revenue in 2023 and is expected to dominate the market during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global angioplasty balloons market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Inc, MEDTRONIC PLC., MicroPort Scientific Corporation, Terumo Corporation, and THE SPECTRANETICS CORPORATION. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.
Key Market Segments
By Type
Normal Balloons
Drug Eluting Balloons
Cutting Balloons
Scoring Balloons
By Application
Peripheral
Coronary
By End User
ASCs
Hospitals
Cath Labs
By Region
North America
U.S.
Canada
Mexico
Europe
France
Germany
Italy
Spain
UK
Rest of Europe
Asia-Pacific
China
Japan
India
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA
Key Market Players
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc
MEDTRONIC PLC.
MicroPort Scientific Corporation
Terumo Corporation
THE SPECTRANETICS CORPORATION
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: ANGIOPLASTY BALLOONS MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Normal Balloons
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Drug Eluting Balloons
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Cutting Balloons
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Scoring Balloons
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
- CHAPTER 5: ANGIOPLASTY BALLOONS MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Peripheral
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Coronary
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- CHAPTER 6: ANGIOPLASTY BALLOONS MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. ASCs
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Hospitals
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Cath Labs
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: ANGIOPLASTY BALLOONS MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Angioplasty Balloons Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Angioplasty Balloons Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Angioplasty Balloons Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. France Angioplasty Balloons Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. Germany Angioplasty Balloons Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Italy Angioplasty Balloons Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Spain Angioplasty Balloons Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. UK Angioplasty Balloons Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Angioplasty Balloons Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. China Angioplasty Balloons Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. Japan Angioplasty Balloons Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Angioplasty Balloons Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. South Korea Angioplasty Balloons Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. Australia Angioplasty Balloons Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Angioplasty Balloons Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Angioplasty Balloons Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa Angioplasty Balloons Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Angioplasty Balloons Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Angioplasty Balloons Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. B. Braun Melsungen AG
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Biotronik SE And Co. KG
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Boston Scientific Corporation
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. C. R. Bard, Inc.
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Cardinal Health, Inc
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. MEDTRONIC PLC.
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. MicroPort Scientific Corporation
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Terumo Corporation
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. THE SPECTRANETICS CORPORATION
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. ANGIOPLASTY BALLOONS MARKET FOR NORMAL BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. ANGIOPLASTY BALLOONS MARKET FOR DRUG ELUTING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. ANGIOPLASTY BALLOONS MARKET FOR CUTTING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. ANGIOPLASTY BALLOONS MARKET FOR SCORING BALLOONS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 7. ANGIOPLASTY BALLOONS MARKET FOR PERIPHERAL, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. ANGIOPLASTY BALLOONS MARKET FOR CORONARY, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. GLOBAL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 10. ANGIOPLASTY BALLOONS MARKET FOR ASCS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. ANGIOPLASTY BALLOONS MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. ANGIOPLASTY BALLOONS MARKET FOR CATH LABS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. ANGIOPLASTY BALLOONS MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 17. NORTH AMERICA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 20. U.S. ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 23. CANADA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 26. MEXICO ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 30. EUROPE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 31. FRANCE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 32. FRANCE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 34. GERMANY ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 35. GERMANY ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 36. GERMANY ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. ITALY ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 38. ITALY ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 40. SPAIN ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 41. SPAIN ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 43. UK ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 44. UK ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 45. UK ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF EUROPE ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 52. ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 53. CHINA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 54. CHINA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 56. JAPAN ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 57. JAPAN ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 58. JAPAN ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 59. INDIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 61. INDIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 62. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 63. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 65. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 66. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 67. AUSTRALIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 70. REST OF ASIA-PACIFIC ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA ANGIOPLASTY BALLOONS MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 74. LAMEA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 77. BRAZIL ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 78. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 79. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 81. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 82. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 83. SAUDI ARABIA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 85. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 86. REST OF LAMEA ANGIOPLASTY BALLOONS MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 87. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 88. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 89. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 90. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 91. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 92. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
- TABLE 93. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
- TABLE 94. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
- TABLE 95. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
- TABLE 96. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
- TABLE 98. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
- TABLE 99. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
- TABLE 100. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
- TABLE 101. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 103. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 104. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 105. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 106. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107. C. R. BARD, INC.: KEY EXECUTIVES
- TABLE 108. C. R. BARD, INC.: COMPANY SNAPSHOT
- TABLE 109. C. R. BARD, INC.: OPERATING SEGMENTS
- TABLE 110. C. R. BARD, INC.: PRODUCT PORTFOLIO
- TABLE 111. C. R. BARD, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 112. CARDINAL HEALTH, INC: KEY EXECUTIVES
- TABLE 113. CARDINAL HEALTH, INC: COMPANY SNAPSHOT
- TABLE 114. CARDINAL HEALTH, INC: OPERATING SEGMENTS
- TABLE 115. CARDINAL HEALTH, INC: PRODUCT PORTFOLIO
- TABLE 116. CARDINAL HEALTH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 117. MEDTRONIC PLC.: KEY EXECUTIVES
- TABLE 118. MEDTRONIC PLC.: COMPANY SNAPSHOT
- TABLE 119. MEDTRONIC PLC.: OPERATING SEGMENTS
- TABLE 120. MEDTRONIC PLC.: PRODUCT PORTFOLIO
- TABLE 121. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 122. MICROPORT SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 123. MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 124. MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 125. MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 126. MICROPORT SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 127. TERUMO CORPORATION: KEY EXECUTIVES
- TABLE 128. TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 129. TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 130. TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 131. TERUMO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 132. THE SPECTRANETICS CORPORATION: KEY EXECUTIVES
- TABLE 133. THE SPECTRANETICS CORPORATION: COMPANY SNAPSHOT
- TABLE 134. THE SPECTRANETICS CORPORATION: OPERATING SEGMENTS
- TABLE 135. THE SPECTRANETICS CORPORATION: PRODUCT PORTFOLIO
- TABLE 136. THE SPECTRANETICS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL ANGIOPLASTY BALLOONS MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF ANGIOPLASTY BALLOONS MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN ANGIOPLASTY BALLOONS MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALANGIOPLASTY BALLOONS MARKET
- FIGURE 10. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY TYPE
- FIGURE 11. ANGIOPLASTY BALLOONS MARKET FOR NORMAL BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. ANGIOPLASTY BALLOONS MARKET FOR DRUG ELUTING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. ANGIOPLASTY BALLOONS MARKET FOR CUTTING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. ANGIOPLASTY BALLOONS MARKET FOR SCORING BALLOONS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY APPLICATION
- FIGURE 16. ANGIOPLASTY BALLOONS MARKET FOR PERIPHERAL, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. ANGIOPLASTY BALLOONS MARKET FOR CORONARY, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. GLOBAL ANGIOPLASTY BALLOONS MARKET SEGMENTATION, BY END USER
- FIGURE 19. ANGIOPLASTY BALLOONS MARKET FOR ASCS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. ANGIOPLASTY BALLOONS MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. ANGIOPLASTY BALLOONS MARKET FOR CATH LABS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 26. COMPETITIVE DASHBOARD
- FIGURE 27. COMPETITIVE HEATMAP: ANGIOPLASTY BALLOONS MARKET
- FIGURE 28. TOP PLAYER POSITIONING, 2023
- FIGURE 29. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 31. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 32. B. BRAUN MELSUNGEN AG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 33. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 34. B. BRAUN MELSUNGEN AG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 35. BIOTRONIK SE AND CO. KG: NET SALES, 2021-2023 ($BILLION)
- FIGURE 36. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 37. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 38. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 39. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 41. C. R. BARD, INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 42. C. R. BARD, INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 43. C. R. BARD, INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 44. CARDINAL HEALTH, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 45. CARDINAL HEALTH, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 46. CARDINAL HEALTH, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 47. MEDTRONIC PLC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 48. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 49. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 50. MICROPORT SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 51. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 52. MICROPORT SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 53. TERUMO CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 54. TERUMO CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 55. TERUMO CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 56. THE SPECTRANETICS CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 57. THE SPECTRANETICS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 58. THE SPECTRANETICS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook